secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2021-10-15T23:59:59+00:00
Accession:  0001104659-21-126794
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharmaceuticals raises ~$5.7M in registered direct offering led by largest shareholder
--------------------------------------------------------------------------------

- Offering of 3,323,616 shares at $1.715 per share; warrants for same number at same price, 5-year term.
- Gross proceeds ~$5.7M; net proceeds ~$5.4M after fees; expected close Oct 18, 2021.
- Proceeds will fund expansion of men's health platform and general corporate purposes.
- Katalyst Securities served as financial advisor; advisory fee and expenses $235,000 plus 130,000 warrants.
- Largest shareholder led the offering; warrants issued in private placement, unregistered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465921126794/0001104659-21-126794-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465921126794/tm2130098d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-126794

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer